Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetic Kidney Disease, Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07476248
What this trial is testing

The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Who this might be right for
Diabetic NephropathyDyslipidemia
Assiut University 84
Post-approval studies (Phase 4)UnknownNCT01316068
What this trial is testing

Effect of Sulodexide on Albuminuria in Chinese Type 2 Diabetic Patients

Who this might be right for
Diabetic NephropathyAlbuminuria
Sun Yat-sen University 80
Large-scale testing (Phase 3)Study completedNCT03164785
What this trial is testing

Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusDiabetic Kidney Disease
Second Xiangya Hospital of Central South University 202
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Not applicableStudy completedNCT00561704
What this trial is testing

Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

Who this might be right for
ObeseType 2 DiabetesDiabetic Nephropathy+2 more
Shanghai Jiao Tong University School of Medicine 80
Not applicableStudy completedNCT04403945
What this trial is testing

The Predictive Value of Sidestream Dark Field Imaging in Diabetic Nephropathy

Who this might be right for
Microcirculation Detection in Diabetic Patients
Third Military Medical University 143
Large-scale testing (Phase 3)WithdrawnNCT03173963
What this trial is testing

Empaglifozin in Early Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney DiseaseDiabetes Mellitus Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Testing effectiveness (Phase 2)Study completedNCT06051565
What this trial is testing

Cardiovascular Contrast-enhanced Magnetic Resonance Imaging Using Polysaccharide Superparamagnetic Iron Oxide Injection in Diabetic Patients

Who this might be right for
DiabetesMagnetic Resonance Imaging
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 12
Large-scale testing (Phase 3)Ended earlyNCT02156843
What this trial is testing

Pyridorin in Diabetic Nephropathy

Who this might be right for
Diabetic NephropathyDiabetic Kidney Disease
NephroGenex, Inc. 328
Large-scale testing (Phase 3)Study completedNCT00552409
What this trial is testing

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Who this might be right for
Diabetes MellitusChronic Kidney DiseaseDiabetic Kidney Disease
University of Washington 22
Not applicableUnknownNCT01566006
What this trial is testing

Mycophenolate Mofetil, Carnitine and PDE5 Inhibitor, Three Potential Treatments for Resistant Proteinuria Slowing Diabetic Nephropathy Deterioration

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
The Nazareth Hospital, Israel 80
Post-approval studies (Phase 4)UnknownNCT04127084
What this trial is testing

Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Zhongshan Hospital Xiamen University 70
Large-scale testing (Phase 3)Ended earlyNCT00108485
What this trial is testing

Study of the Use of Niaspan for Treatment of Dyslipidemia in Diabetic Nephropathy

Who this might be right for
Diabetes Mellitus, Type 2Kidney Failure, ChronicHyperlipidemia
University of Miami 9
Testing effectiveness (Phase 2)Study completedNCT03270956
What this trial is testing

Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease
Prokidney 10
Testing effectiveness (Phase 2)Study completedNCT01053936
What this trial is testing

Phase II Pharmacodynamic Trial to Determine the Effects of Bardoxolone Methyl on eGFR in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Biogen 129
Post-approval studies (Phase 4)Study completedNCT02682563
What this trial is testing

Renoprotective Effects of Dapagliflozin in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2Diabetic Nephropathies
M.H.H. Kramer 44
Not applicableStudy completedNCT00728143
What this trial is testing

Blood Glucose Response to Highly Viscous Polysaccharide Enriched Biscuits in Healthy and Diabetic Subjects

Who this might be right for
Type 2 Diabetes
Unity Health Toronto 19
Not applicableStudy completedNCT00361023
What this trial is testing

Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Shanghai Jiao Tong University School of Medicine 25
Post-approval studies (Phase 4)Study completedNCT06224790
What this trial is testing

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

Who this might be right for
Diabetic NephropathiesType 2 Diabetes
Sidrah Lodhi 60
Next Page